Ibogaine is a naturally occurring alkaloid that has been claimed to be
effective in treating addiction to opioids and stimulants; a single d
ose is claimed to be effective for 6 months. Analogously, studies in r
ats have demonstrated prolonged (one or more days) effects of ibogaine
on morphine and cocaine self-administration even though ibogaine is m
ostly eliminated from the body in several hours. These observations ha
ve suggested that a metabolite may mediate some of the effects of ibog
aine. Recently, noribogaine was identified as a metabolite of ibogaine
. Accordingly, the present study sought to determine, in rats, whether
noribogaine had pharmacological effects mimicking those of ibogaine.
Noribogaine (40 mg/kg) was found to decrease morphine and cocaine self
-administration, reduce the locomotor stimulant effect of morphine, an
d decrease extracellular levels of dopamine in the nucleus accumbens a
nd striatum. All of these effects were similar to effects previously o
bserved with ibogaine (40 mg/kg); however, noribogaine did not induce
any ibogaine-like tremors. The results suggest that noribogaine may be
a mediator of ibogaine's putative anti-addictive effects.